The Scientific Research Team at Arch Biopartners is dedicated to pioneering innovative therapeutic solutions by conducting cutting-edge research in peptide technology and inflammation treatments. Comprising lead scientists with specialized expertise in Lsalt and BORG peptide teams, the group focuses on developing and optimizing products that cater to the pharmaceutical and industrial sectors. Their efforts drive the advancement of scientific knowledge while enabling the commercialization of novel biotechnological products.
Arthur Lau
Lead Scientist & Project Manag...
Dongyang Li
Lead Scientist, BORG Peptide T...
Donna Senger
Lead Scientist, LSALT Peptide ...
Elisabeth Davis
Lead Scientist, BORG Peptide T...
Justin MacDonald
Lead Scientist, Treatments for...
Paul Beck
Lead Scientist, Treatments for...
Randall Irvin
Lead Scientist, BORG Peptide T...
Stephen Robbins
Lead Scientist, LSALT Peptide ...
View all